MedPath

Treatment of heavy menstrual bleeding with Unani tablet

Phase 2
Conditions
Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle
Registration Number
CTRI/2023/07/055758
Lead Sponsor
uqman Unani Medical College Hospital and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Married and unmarried patients of reproductive age women 18to 45 years

Heavy menstrual bleeding in terms of amount PBAC score above 100 or duration more than 7 days in duration for at least three months

Exclusion Criteria

Malignancy

Coagulopathies

systemic and metabolic illness

Pelvic inflammatory disease

Thyroid dysfunctions

Severe anaemia Hb less than8gm percentage

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath